Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzone Serologic Responses in Infants
NCT00885105Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2005
- Primary completion
- Jan 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Fluzone Trivalent in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Summary of Influenza Seroprotection Post-vaccination With Fluzone® Vaccine at Day 28. Started Oct 2005; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00885105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885105.